Bortezomib plus dexamethasone results in a late organ response in primary heavy-chain amyloidosis without a hematologic response
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
King Faisal Specialist Hospital and Research Centre
Abstract
Description
Keywords
Amyloidosis, Anemia, Biopsy, Bortezomib, Dexamethasone, Disease progression, Glomerulosclerosis, focal segmental, Glucocorticoids, Humans, Immunoglobulin heavy chains, Male, Microscopy, fluorescence, Middle aged, Proteinuria, Renal insufficiency, Treatment outcome, Apolipoprotein e, Immunoglobulin g, Immunoglobulin g kappa, Immunoglobulin heavy chain, Immunoglobulin kappa chain, Immunoglobulin lambda chain, Serum amyloid p, Unclassified drug, Glucocorticoid, Adult, Bone marrow biopsy, Case report, Differential diagnosis, Disease association, Disease course, Disease duration, Drug response, Electrophoresis, Fine needle aspiration biopsy, Fluorescence in situ hybridization, Focal global glomerulosclerosis, Focal glomerulosclerosis, Heavy chain renal amyloidosis, Human, Karyotype, Kidney amyloidosis, Kidney biopsy, Kidney failure, Late organ response, Letter, Maintenance therapy, Mass spectrometry, Monoclonal immunoglobulinemia, Multiple cycle treatment, Outcome assessment, Plasma cell, Treatment duration, Urinalysis, Chemistry, Complication, Fluorescence microscopy